{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T20:25:13Z","timestamp":1774556713236,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004282","name":"Evelyn Trust","doi-asserted-by":"publisher","award":["16\/33"],"award-info":[{"award-number":["16\/33"]}],"id":[{"id":"10.13039\/501100004282","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Cambridge Biomedical Research Centre","award":["146281"],"award-info":[{"award-number":["146281"]}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00014\/4"],"award-info":[{"award-number":["MC_UU_00014\/4"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T016701\/1"],"award-info":[{"award-number":["MR\/T016701\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["220033\/Z\/19\/Z"],"award-info":[{"award-number":["220033\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/19\/54\/34889C"],"award-info":[{"award-number":["FS\/19\/54\/34889C"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/4yPhD\/F\/20\/34124C"],"award-info":[{"award-number":["FS\/4yPhD\/F\/20\/34124C"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/20\/11\/34957"],"award-info":[{"award-number":["PG\/20\/11\/34957"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/17\/12\/33167"],"award-info":[{"award-number":["RG\/17\/12\/33167"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims\/hypothesis<\/jats:title>\n                <jats:p>Metformin is increasingly used therapeutically during pregnancy worldwide, particularly in the treatment of gestational diabetes, which affects a substantial proportion of pregnant women globally. However, the impact on placental metabolism remains unclear. In view of the association between metformin use in pregnancy and decreased birthweight, it is essential to understand how metformin modulates the bioenergetic and anabolic functions of the placenta.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cohort of 55 placentas delivered by elective Caesarean section at term was collected from consenting participants. Trophoblasts were isolated from the placental samples and treated in vitro with clinically relevant doses of metformin (0.01 mmol\/l or 0.1 mmol\/l) or vehicle. Respiratory function was assayed using high-resolution respirometry to measure oxygen concentration and calculated <jats:inline-formula><jats:alternatives><jats:tex-math>$${\\dot{V}\\mathrm{O}}_{2}$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                    <mml:msub>\n                      <mml:mrow>\n                        <mml:mover>\n                          <mml:mi>V<\/mml:mi>\n                          <mml:mo>\u02d9<\/mml:mo>\n                        <\/mml:mover>\n                        <mml:mi>O<\/mml:mi>\n                      <\/mml:mrow>\n                      <mml:mn>2<\/mml:mn>\n                    <\/mml:msub>\n                  <\/mml:math><\/jats:alternatives><\/jats:inline-formula>. Glycolytic rate and glycolytic stress assays were performed using Agilent Seahorse XF assays. Fatty acid uptake and oxidation measurements were conducted using radioisotope-labelled assays. Lipidomic analysis was conducted using LC-MS. Gene expression and protein analysis were performed using RT-PCR and western blotting, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Complex I-supported oxidative phosphorylation was lower in metformin-treated trophoblasts (0.01 mmol\/l metformin, 61.7% of control, <jats:italic>p<\/jats:italic>&lt;0.05; 0.1 mmol\/l metformin, 43.1% of control, <jats:italic>p<\/jats:italic>&lt;0.001). The proton efflux rate arising from glycolysis under physiological conditions was increased following metformin treatment, up to 23\u00b15% above control conditions following treatment with 0.1 mmol\/l metformin (<jats:italic>p<\/jats:italic>&lt;0.01). There was a significant increase in triglyceride concentrations in trophoblasts treated with 0.1 mmol\/l metformin (<jats:italic>p<\/jats:italic>&lt;0.05), particularly those of esters of long-chain polyunsaturated fatty acids. Fatty acid oxidation was reduced by ~50% in trophoblasts treated with 0.1 mmol\/l metformin compared with controls (<jats:italic>p<\/jats:italic>&lt;0.001), with no difference in uptake between treatment groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions\/interpretation<\/jats:title>\n                <jats:p>In primary trophoblasts derived from term placentas metformin treatment caused a reduction in oxidative phosphorylation through partial inactivation of complex I and potentially by other mechanisms. Metformin-treated trophoblasts accumulate lipids, particularly long- and very-long-chain polyunsaturated fatty acids. Our findings raise clinically important questions about the balance of risk of metformin use during pregnancy, particularly in situations where the benefits are not clear-cut and alternative therapies are available.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00125-023-05996-3","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T22:03:18Z","timestamp":1693951398000},"page":"2320-2331","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The metabolic response of human trophoblasts derived from term placentas to metformin"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9569-6132","authenticated-orcid":false,"given":"Jane L.","family":"Tarry-Adkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"India G.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5626-8810","authenticated-orcid":false,"given":"Lucas C.","family":"Pantale\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna L.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin D.","family":"Thackray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenz M. W.","family":"Holzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice E.","family":"Knapton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9545-5432","authenticated-orcid":false,"given":"Sam","family":"Virtue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9998-051X","authenticated-orcid":false,"given":"Albert","family":"Koulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0929-9315","authenticated-orcid":false,"given":"Andrew J.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8753-5144","authenticated-orcid":false,"given":"Susan E.","family":"Ozanne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6510-5626","authenticated-orcid":false,"given":"Catherine E.","family":"Aiken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"key":"5996_CR1","unstructured":"International Diabetes Federation (2021) IDF Diabetes Atlas. IDF, Belgium: 2021. Available at: https:\/\/www.diabetesatlas.org. Last accessed 16\/02\/2023"},{"issue":"10","key":"5996_CR2","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","volume":"8","author":"DS Feig","year":"2020","unstructured":"Feig DS, Donovan LE, Zinman B et al (2020) Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol 8(10):834\u2013844. https:\/\/doi.org\/10.1016\/S2213-8587(20)30310-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"5996_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12958-022-00905-6","volume":"20","author":"R Fornes","year":"2022","unstructured":"Fornes R, Simin J, Nguyen MH et al (2022) Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study. Reprod Biol Endocrinol 20(1):30. https:\/\/doi.org\/10.1186\/s12958-022-00905-6","journal-title":"Reprod Biol Endocrinol"},{"key":"5996_CR4","doi-asserted-by":"publisher","first-page":"n2103","DOI":"10.1136\/bmj.n2103","volume":"374","author":"CA Cluver","year":"2021","unstructured":"Cluver CA, Hiscock R, Decloedt EH et al (2021) Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial. BMJ 374:n2103. https:\/\/doi.org\/10.1136\/bmj.n2103","journal-title":"BMJ"},{"issue":"Suppl 1","key":"5996_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12802","volume":"145","author":"LC Poon","year":"2019","unstructured":"Poon LC, Shennan A, Hyett JA et al (2019) The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet 145(Suppl 1):1\u201333. https:\/\/doi.org\/10.1002\/ijgo.12802","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"5996_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/01.ftd.0000184161.52573.0e","volume":"28","author":"B Charles","year":"2006","unstructured":"Charles B, Norris R, Xiao X, Hague W (2006) Population pharmacokinetics of metformin in late pregnancy. Ther Drug Monit 28(1):67\u201372. https:\/\/doi.org\/10.1097\/01.ftd.0000184161.52573.0e","journal-title":"Ther Drug Monit"},{"key":"5996_CR7","doi-asserted-by":"publisher","first-page":"935403","DOI":"10.3389\/fcell.2022.935403","volume":"10","author":"JL Tarry-Adkins","year":"2022","unstructured":"Tarry-Adkins JL, Robinson IG, Reynolds RM et al (2022) Impact of metformin treatment on human placental energy production and oxidative stress. Front Cell Dev Biol 10:935403. https:\/\/doi.org\/10.3389\/fcell.2022.935403","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"5996_CR8","doi-asserted-by":"publisher","first-page":"e010210","DOI":"10.1136\/bmjopen-2015-010210","volume":"6","author":"M Sharma","year":"2016","unstructured":"Sharma M, Nazareth I, Petersen I (2016) Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study. BMJ Open 6(1):e010210. https:\/\/doi.org\/10.1136\/bmjopen-2015-010210","journal-title":"BMJ Open"},{"issue":"7","key":"5996_CR9","doi-asserted-by":"publisher","first-page":"e022768","DOI":"10.1136\/bmjopen-2018-022768","volume":"8","author":"S Wilkinson","year":"2018","unstructured":"Wilkinson S, Douglas I, Stirnadel-Farrant H et al (2018) Changing use of antidiabetic drugs in the UK: trends in prescribing 2000\u20132017. BMJ Open 8(7):e022768. https:\/\/doi.org\/10.1136\/bmjopen-2018-022768","journal-title":"BMJ Open"},{"issue":"8","key":"5996_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/jci13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou G, Myers R, Li Y et al (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108(8):1167\u20131174. https:\/\/doi.org\/10.1172\/jci13505","journal-title":"J Clin Invest"},{"issue":"2","key":"5996_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.clnu.2012.08.006","volume":"32","author":"A Esteghamati","year":"2013","unstructured":"Esteghamati A, Eskandari D, Mirmiranpour H et al (2013) Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: a randomized clinical trial. Clin Nutr 32(2):179\u2013185. https:\/\/doi.org\/10.1016\/j.clnu.2012.08.006","journal-title":"Clin Nutr"},{"issue":"7795","key":"5996_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","volume":"578","author":"AP Coll","year":"2020","unstructured":"Coll AP, Chen M, Taskar P et al (2020) GDF15 mediates the effects of metformin on body weight and energy balance. Nature 578(7795):444\u2013448. https:\/\/doi.org\/10.1038\/s41586-019-1911-y","journal-title":"Nature"},{"key":"5996_CR13","doi-asserted-by":"publisher","first-page":"1022739","DOI":"10.3389\/fgene.2022.1022739","volume":"13","author":"S Goel","year":"2022","unstructured":"Goel S, Singh R, Singh V et al (2022) Metformin: activation of 5\u2019 AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action. Front Genet 13:1022739. https:\/\/doi.org\/10.3389\/fgene.2022.1022739","journal-title":"Front Genet"},{"issue":"5","key":"5996_CR14","doi-asserted-by":"publisher","first-page":"e1003126","DOI":"10.1371\/journal.pmed.1003126","volume":"17","author":"JL Tarry-Adkins","year":"2020","unstructured":"Tarry-Adkins JL, Aiken CE, Ozanne SE (2020) Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: A systematic review and meta-analysis. PLoS Med 17(5):e1003126. https:\/\/doi.org\/10.1371\/journal.pmed.1003126","journal-title":"PLoS Med"},{"issue":"8","key":"5996_CR15","doi-asserted-by":"publisher","first-page":"e1002848","DOI":"10.1371\/journal.pmed.1002848","volume":"16","author":"JL Tarry-Adkins","year":"2019","unstructured":"Tarry-Adkins JL, Aiken CE, Ozanne SE (2019) Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis. PLoS Med 16(8):e1002848. https:\/\/doi.org\/10.1371\/journal.pmed.1002848","journal-title":"PLoS Med"},{"issue":"1","key":"5996_CR16","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/s41467-021-22272-3","volume":"12","author":"A Whitehead","year":"2021","unstructured":"Whitehead A, Krause FN, Moran A et al (2021) Brown and beige adipose tissue regulate systemic metabolism through a metabolite interorgan signaling axis. Nat Commun 12(1):1905. https:\/\/doi.org\/10.1038\/s41467-021-22272-3","journal-title":"Nat Commun"},{"key":"5996_CR17","doi-asserted-by":"publisher","first-page":"e69078","DOI":"10.7554\/eLife.69078","volume":"11","author":"LC Pantale\u00e3o","year":"2022","unstructured":"Pantale\u00e3o LC, Inzani I, Furse S et al (2022) Maternal diet-induced obesity during pregnancy alters lipid supply to mouse E18.5 fetuses and changes the cardiac tissue lipidome in a sex-dependent manner. Elife 11:e69078. https:\/\/doi.org\/10.7554\/eLife.69078","journal-title":"Elife"},{"issue":"7","key":"5996_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/metabo10070296","volume":"10","author":"B Jenkins","year":"2020","unstructured":"Jenkins B, Ronis M, Koulman A (2020) LC-MS lipidomics: exploiting a simple high-throughput method for the comprehensive extraction of lipids in a ruminant fat dose-response study. Metabolites 10(7):296. https:\/\/doi.org\/10.3390\/metabo10070296","journal-title":"Metabolites"},{"issue":"5","key":"5996_CR19","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1096\/fj.08-122796","volume":"23","author":"JL Tarry-Adkins","year":"2009","unstructured":"Tarry-Adkins JL, Chen JH, Smith NS, Jones RH, Cherif H, Ozanne SE (2009) Poor maternal nutrition followed by accelerated postnatal growth leads to telomere shortening and increased markers of cell senescence in rat islets. FASEB J 23(5):1521\u20131528. https:\/\/doi.org\/10.1096\/fj.08-122796","journal-title":"FASEB J"},{"issue":"1","key":"5996_CR20","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1038\/s41598-018-22383-w","volume":"8","author":"JL Tarry-Adkins","year":"2018","unstructured":"Tarry-Adkins JL, Aiken CE, Ashmore TJ, Ozanne SE (2018) Insulin-signalling dysregulation and inflammation is programmed trans-generationally in a female rat model of poor maternal nutrition. Sci Rep 8(1):4014. https:\/\/doi.org\/10.1038\/s41598-018-22383-w","journal-title":"Sci Rep"},{"key":"5996_CR21","unstructured":"R Core Team (2018) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https:\/\/www.R-project.org\/"},{"issue":"7506","key":"5996_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"AK Madiraju","year":"2014","unstructured":"Madiraju AK, Erion DM, Rahimi Y et al (2014) Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510(7506):542\u2013546. https:\/\/doi.org\/10.1038\/nature13270","journal-title":"Nature"},{"key":"5996_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2049-3002-2-12","volume":"2","author":"S Andrzejewski","year":"2014","unstructured":"Andrzejewski S, Gravel SP, Pollak M, St-Pierre J (2014) Metformin directly acts on mitochondria to alter cellular bioenergetics. Cancer Metab 2:12. https:\/\/doi.org\/10.1186\/2049-3002-2-12","journal-title":"Cancer Metab"},{"issue":"5","key":"5996_CR24","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1083\/jcb.201201139","volume":"198","author":"N Xu","year":"2012","unstructured":"Xu N, Zhang SO, Cole RA et al (2012) The FATP1-DGAT2 complex facilitates lipid droplet expansion at the ER-lipid droplet interface. J Cell Biol 198(5):895\u2013911. https:\/\/doi.org\/10.1083\/jcb.201201139","journal-title":"J Cell Biol"},{"key":"5996_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fendo.2019.00294","volume":"10","author":"G Vial","year":"2019","unstructured":"Vial G, Detaille D, Guigas B (2019) Role of mitochondria in the mechanism(s) of action of metformin. Front Endocrinol (Lausanne) 10:294. https:\/\/doi.org\/10.3389\/fendo.2019.00294","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Pt 3","key":"5996_CR26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj3480607","volume":"348","author":"MR Owen","year":"2000","unstructured":"Owen MR, Doran E, Halestrap AP (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348(Pt 3):607\u2013614. https:\/\/doi.org\/10.1042\/bj3480607","journal-title":"Biochem J"},{"issue":"1","key":"5996_CR27","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1038\/s41598-021-81349-7","volume":"11","author":"M Yang","year":"2021","unstructured":"Yang M, Darwish T, Larraufie P et al (2021) Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells. Sci Rep 11(1):2529. https:\/\/doi.org\/10.1038\/s41598-021-81349-7","journal-title":"Sci Rep"},{"key":"5996_CR28","doi-asserted-by":"publisher","first-page":"930308","DOI":"10.3389\/fphar.2022.930308","volume":"13","author":"K Pavlovic","year":"2022","unstructured":"Pavlovic K, Krako Jakovljevic N, Isakovic AM, Ivanovic T, Markovic I, Lalic NM (2022) Therapeutic vs. suprapharmacological metformin concentrations: different effects on energy metabolism and mitochondrial function in skeletal muscle cells. Front Pharmacol 13:930308. https:\/\/doi.org\/10.3389\/fphar.2022.930308","journal-title":"Front Pharmacol"},{"issue":"2S","key":"5996_CR29","doi-asserted-by":"publisher","first-page":"S928","DOI":"10.1016\/j.ajog.2020.11.005","volume":"226","author":"ILMH Aye","year":"2022","unstructured":"Aye ILMH, Aiken CE, Charnock-Jones DS, Smith GCS (2022) Placental energy metabolism in health and disease-significance of development and implications for preeclampsia. Am J Obstet Gynecol 226(2S):S928\u2013S944. https:\/\/doi.org\/10.1016\/j.ajog.2020.11.005","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"5996_CR30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/14767058.2012.715006","volume":"26","author":"S Longo","year":"2013","unstructured":"Longo S, Bollani L, Decembrino L, Di Comite A, Angelini M, Stronati M (2013) Short-term and long-term sequelae in intrauterine growth retardation (IUGR). J Matern Fetal Neonatal Med 26(3):222\u2013225. https:\/\/doi.org\/10.3109\/14767058.2012.715006","journal-title":"J Matern Fetal Neonatal Med"},{"key":"5996_CR31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.reprotox.2020.10.005","volume":"99","author":"JB Armengaud","year":"2021","unstructured":"Armengaud JB, Yzydorczyk C, Siddeek B, Peyter AC, Simeoni U (2021) Intrauterine growth restriction: clinical consequences on health and disease at adulthood. Reprod Toxicol 99:168\u2013176. https:\/\/doi.org\/10.1016\/j.reprotox.2020.10.005","journal-title":"Reprod Toxicol"},{"issue":"3","key":"5996_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.pbi.2004.03.007","volume":"7","author":"AR Fernie","year":"2004","unstructured":"Fernie AR, Carrari F, Sweetlove LJ (2004) Respiratory metabolism: glycolysis, the TCA cycle and mitochondrial electron transport. Curr Opin Plant Biol 7(3):254\u2013261. https:\/\/doi.org\/10.1016\/j.pbi.2004.03.007","journal-title":"Curr Opin Plant Biol"},{"issue":"1","key":"5996_CR33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS (2020) Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun 11(1):102. https:\/\/doi.org\/10.1038\/s41467-019-13668-3","journal-title":"Nat Commun"},{"issue":"5","key":"5996_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.earlhumdev.2006.11.003","volume":"83","author":"EE Birch","year":"2007","unstructured":"Birch EE, Garfield S, Casta\u00f1eda Y, Hughbanks-Wheaton D, Uauy R, Hoffman D (2007) Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early Hum Dev 83(5):279\u2013284. https:\/\/doi.org\/10.1016\/j.earlhumdev.2006.11.003","journal-title":"Early Hum Dev"},{"issue":"4","key":"5996_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0378-3782(81)90016-5","volume":"5","author":"MT Clandinin","year":"1981","unstructured":"Clandinin MT, Chappell JE, Heim T, Swyer PR, Chance GW (1981) Fatty acid utilization in perinatal de novo synthesis of tissues. Early Hum Dev 5(4):355\u2013366. https:\/\/doi.org\/10.1016\/0378-3782(81)90016-5","journal-title":"Early Hum Dev"},{"issue":"3","key":"5996_CR36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/ajcn\/87.3.548","volume":"87","author":"SM Innis","year":"2008","unstructured":"Innis SM, Friesen RW (2008) Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants. Am J Clin Nutr 87(3):548\u2013557. https:\/\/doi.org\/10.1093\/ajcn\/87.3.548","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"5996_CR37","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.2174\/1389200214666131211153933","volume":"14","author":"S Chen","year":"2013","unstructured":"Chen S, Zhou J, Xi M et al (2013) Pharmacogenetic variation and metformin response. Curr Drug Metab 14(10):1070\u20131082. https:\/\/doi.org\/10.2174\/1389200214666131211153933","journal-title":"Curr Drug Metab"},{"issue":"4","key":"5996_CR38","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1210\/endo-118-4-1567","volume":"118","author":"HJ Kliman","year":"1986","unstructured":"Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF 3rd (1986) Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118(4):1567\u20131582. https:\/\/doi.org\/10.1210\/endo-118-4-1567","journal-title":"Endocrinology"},{"issue":"19","key":"5996_CR39","doi-asserted-by":"publisher","first-page":"10875","DOI":"10.3390\/ijms221910875","volume":"22","author":"M Bucher","year":"2021","unstructured":"Bucher M, Kadam L, Ahuna K, Myatt L (2021) Differences in glycolysis and mitochondrial respiration between cytotrophoblast and syncytiotrophoblast in-vitro: evidence for sexual dimorphism. Int J Mol Sci 22(19):10875. https:\/\/doi.org\/10.3390\/ijms221910875","journal-title":"Int J Mol Sci"},{"issue":"15","key":"5996_CR40","doi-asserted-by":"publisher","first-page":"8105","DOI":"10.3390\/ijms22158104","volume":"22","author":"JM Schoonejans","year":"2021","unstructured":"Schoonejans JM, Blackmore HL, Ashmore TJ, Aiken CE, Fernandez-Twinn DS, Ozanne SE (2021) Maternal metformin intervention during obese glucose-intolerant pregnancy affects adiposity in young adult mouse offspring in a sex-specific manner. Int J Mol Sci 22(15):8105. https:\/\/doi.org\/10.3390\/ijms22158104","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5996_CR41","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1113\/JP281902","volume":"600","author":"A Hufnagel","year":"2022","unstructured":"Hufnagel A, Fernandez-Twinn DS, Blackmore HL et al (2022) Maternal but not fetoplacental health can be improved by metformin in a murine diet-induced model of maternal obesity and glucose intolerance. J Physiol 600(4):903\u2013919. https:\/\/doi.org\/10.1113\/JP281902","journal-title":"J Physiol"},{"issue":"3","key":"5996_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s2213-8587(23)00004-9","volume":"11","author":"DS Feig","year":"2023","unstructured":"Feig DS, Sanchez JJ, Murphy KE et al (2023) Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial. Lancet Diabetes Endocrinol 11(3):191\u2013202. https:\/\/doi.org\/10.1016\/s2213-8587(23)00004-9","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"5996_CR43","doi-asserted-by":"publisher","first-page":"9240","DOI":"10.1038\/s41598-021-88650-5","volume":"11","author":"JL Tarry-Adkins","year":"2021","unstructured":"Tarry-Adkins JL, Ozanne SE, Aiken CE (2021) Impact of metformin treatment during pregnancy on maternal outcomes: a systematic review\/meta-analysis. Sci Rep 11(1):9240. https:\/\/doi.org\/10.1038\/s41598-021-88650-5","journal-title":"Sci Rep"},{"issue":"2","key":"5996_CR44","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/jcm9020599","volume":"9","author":"H Nijs","year":"2020","unstructured":"Nijs H, Benhalima K (2020) Gestational diabetes mellitus and the long-term risk for glucose intolerance and overweight in the offspring: a narrative review. J Clin Med 9(2):599. https:\/\/doi.org\/10.3390\/jcm9020599","journal-title":"J Clin Med"},{"key":"5996_CR45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2147\/vhrm.S20181","volume":"7","author":"J Uzan","year":"2011","unstructured":"Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM (2011) Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag 7:467\u2013474. https:\/\/doi.org\/10.2147\/vhrm.S20181","journal-title":"Vasc Health Risk Manag"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-023-05996-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-023-05996-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-023-05996-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T12:01:57Z","timestamp":1699272117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-023-05996-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["5996"],"URL":"https:\/\/doi.org\/10.1007\/s00125-023-05996-3","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"17 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Data are available upon request to the corresponding author.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"This research was funded by a Medical Research Council New Investigator Grant (MR\/T016701\/1) to CEA. CEA, BJ and AK are supported by the NIHR Cambridge Biomedical Research Centre (146281). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. SEO is supported by the Medical Research Council (MC_UU_00014\/4) and the British Heart Foundation (RG\/17\/12\/33167 and PG\/20\/11\/34957). AJM is supported by the Evelyn Trust (16\/33), Gates Foundation, British Heart Foundation (FS\/4yPhD\/F\/20\/34124C and FS\/19\/54\/34889C) and Wellcome Trust (220033\/Z\/19\/Z).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"CEA, SEO, AJM, IGR and AK were responsible for conception and design of the experiments. JLT-A, IGR, LCP, JLA, BDT, LMWH, AEK, SV and BJ performed experiments. CEA, SEO, AJM, IGR, AK and BJ analysed and interpreted the data. CEA and JLT-A drafted the manuscript. All authors critically evaluated and discussed the manuscript. All authors approved the final version. CEA designed experiments, contributed to discussion, analysed and interpreted the data, and wrote and critically evaluated the manuscript. CEA is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis and controlled the decision to publish.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}